Financials in USD. Standardized financial statements.
A compact view of how Albireo Pharma, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $40.58M | $8.31M | $9.64M | $12.74M | $1,000 | $11.36M | $0 | $0 | $0 | $0 |
| Revenue Growth? | +388.4% | -13.8% | -24.4% | +1273900.0% | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1.36M | $0 | $2.21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $39.22M | $8.31M | $7.43M | $12.74M | $1,000 | $11.36M | $0 | $0 | $0 | $0 |
| Gross Margin? | +96.7% | +100.0% | +77.1% | +100.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $162.71M | $104.58M | $70.75M | $50.63M | $24.58M | $23.66M | $19.77M | $19.26M | $20.59M | $19.30M |
| Operating Income? | -$123.48M | -$96.27M | -$61.11M | -$37.89M | -$24.58M | -$12.29M | -$20.77M | -$24.37M | -$20.54M | -$19.30M |
| EBITDA? | -$19.82M | -$96.08M | -$57.29M | -$37.84M | -$24.13M | -$14.96M | -$20.58M | -$23.77M | -$19.90M | -$21.51M |
| Income Before Tax | -$34.03M | -$107.63M | -$62.72M | -$46.09M | -$24.20M | -$16.29M | -$18.71M | -$14.11M | -$19.32M | -$20.73M |
| Income Tax Expense | $117.32M | $11.36M | $8.99M | $20,000 | $212,000 | $62,000 | $29,000 | $26,000 | $15,000 | $18,000 |
| Net Income? | -$151.35M | -$119.00M | -$71.70M | -$46.11M | -$24.41M | -$16.35M | -$18.74M | -$14.13M | -$19.34M | -$20.75M |
| EPS? | $-7.87 | $-7.45 | $-5.77 | $-3.94 | $-3.12 | $-13.19 | $-13.70 | $-19.81 | $-37.06 | $-57.19 |
| Diluted EPS? | $-7.87 | $-7.45 | $-5.77 | $-3.94 | $-3.12 | $-13.19 | $-13.70 | $-19.80 | $-37.20 | $-57.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality